| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50090-6913-0 | 50090-6913 | HUMAN PRESCRIPTION DRUG | Gemfibrozil | gemfibrozil | TABLET | ORAL | 20231212 | N/A | ANDA | ANDA079072 | A-S Medication Solutions | GEMFIBROZIL | 600 mg/1 | 60 TABLET in 1 BOTTLE (50090-6913-0) |
| 50090-6913-2 | 50090-6913 | HUMAN PRESCRIPTION DRUG | Gemfibrozil | gemfibrozil | TABLET | ORAL | 20231212 | N/A | ANDA | ANDA079072 | A-S Medication Solutions | GEMFIBROZIL | 600 mg/1 | 90 TABLET in 1 BOTTLE (50090-6913-2) |
| 50090-6913-3 | 50090-6913 | HUMAN PRESCRIPTION DRUG | Gemfibrozil | gemfibrozil | TABLET | ORAL | 20231212 | N/A | ANDA | ANDA079072 | A-S Medication Solutions | GEMFIBROZIL | 600 mg/1 | 30 TABLET in 1 BOTTLE (50090-6913-3) |
| 50090-6913-4 | 50090-6913 | HUMAN PRESCRIPTION DRUG | Gemfibrozil | gemfibrozil | TABLET | ORAL | 20231212 | N/A | ANDA | ANDA079072 | A-S Medication Solutions | GEMFIBROZIL | 600 mg/1 | 180 TABLET in 1 BOTTLE (50090-6913-4) |
| 50090-6939-0 | 50090-6939 | HUMAN PRESCRIPTION DRUG | Gemfibrozil | gemfibrozil | TABLET | ORAL | 20231215 | N/A | ANDA | ANDA079072 | A-S Medication Solutions | GEMFIBROZIL | 600 mg/1 | 90 TABLET in 1 BOTTLE (50090-6939-0) |
| 16714-101-02 | 16714-101 | HUMAN PRESCRIPTION DRUG | Gemfibrozil | gemfibrozil | TABLET | ORAL | 20101220 | N/A | ANDA | ANDA079072 | Northstar RxLLC | GEMFIBROZIL | 600 mg/1 | 60 TABLET in 1 BOTTLE (16714-101-02) |
| 16714-101-05 | 16714-101 | HUMAN PRESCRIPTION DRUG | Gemfibrozil | gemfibrozil | TABLET | ORAL | 20101220 | N/A | ANDA | ANDA079072 | Northstar RxLLC | GEMFIBROZIL | 600 mg/1 | 500 TABLET in 1 BOTTLE (16714-101-05) |